QHP Capital Acquires Applied StemCell to Support Market Expansion.

MANews-(C)2009-2023

US-based healthcare-focussed investment company QHP Capital has acquired California-based cell and gene therapy CRO/CDMO Applied StemCell, Inc. (ASC), to support continued growth and market expansion, the company said.

Terms of the transaction were not disclosed.

ASC is focussed on supporting the research community and biotechnology industry in developing and manufacturing cell and gene products.

With over 15 years of gene-editing and stem cell expertise, ASC offers comprehensive and customised cell and...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT